Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.
Coordinate Induction of Humoral and Spike Specific T-Cell Response in a Cohort of Italian Health Care Workers Receiving BNT162b2 mRNA Vaccine.
复制标题
DOI:
10.3390/microorganisms9061315
复制
发表时间:
2021-06-16
期刊:
影响因子:
4.5
通讯作者:
On Behalf Of The Inmi Covid-Vaccine Study Group
中科院分区:
文献类型:
--
作者:
Agrati C;Castilletti C;Goletti D;Meschi S;Sacchi A;Matusali G;Bordoni V;Petrone L;Lapa D;Notari S;Vanini V;Colavita F;Aiello A;Agresta A;Farroni C;Grassi G;Leone S;Vaia F;Capobianchi MR;Ippolito G;Puro V;On Behalf Of The Inmi Covid-Vaccine Study Group
Vaccination is the main public health measure to reduce SARS-CoV-2 transmission and hospitalization, and a massive worldwide scientific effort resulted in the rapid development of effective vaccines. This work aimed to define the dynamics of humoral and cell-mediated immune response in a cohort of health care workers (HCWs) who received a two-dose BNT162b2-mRNA vaccination. The serological response was evaluated by quantifying the anti-RBD and neutralizing antibodies. The cell-mediated response was performed by a whole blood test quantifying Th1 cytokines (IFN-γ, TNF-α, IL-2), produced in response to spike peptides. The BNT162b2-mRNA vaccine induced both humoral and cell-mediated immune responses against spike peptides in virtually all HCWs without previous SARS-CoV-2 infection, with a moderate inverse relation with age in the anti-RBD response. Spike-specific T cells produced several Th1 cytokines (IFN-γ, TNF-α, and IL-2), which correlated with the specific-serological response. Overall, our study describes the ability of the BNT162b2 mRNA vaccine to elicit a coordinated neutralizing humoral and spike-specific T cell response in HCWs. Assessing the dynamics of these parameters by an easy immune monitoring protocol can allow for the evaluation of the persistence of the vaccine response in order to define the optimal vaccination strategy.
登录
查看更多内容
DOI:
10.1056/nejmoa2034577
发表时间:
2020-12-31
期刊:
The New England journal of medicine
影响因子:
--
作者:
Polack FP;Thomas SJ;Kitchin N;Absalon J;Gurtman A;Lockhart S;Perez JL;Pérez Marc G;Moreira ED;Zerbini C;Bailey R;Swanson KA;Roychoudhury S;Koury K;Li P;Kalina WV;Cooper D;Frenck RW Jr;Hammitt LL;Türeci Ö;Nell H;Schaefer A;Ünal S;Tresnan DB;Mather S;Dormitzer PR;Şahin U;Jansen KU;Gruber WC;C4591001 Clinical Trial Group
通讯作者:
C4591001 Clinical Trial Group
DOI:
10.1016/j.cmi.2020.09.051
发表时间:
2021-03
期刊:
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases
影响因子:
--
作者:
Petrone L;Petruccioli E;Vanini V;Cuzzi G;Najafi Fard S;Alonzi T;Castilletti C;Palmieri F;Gualano G;Vittozzi P;Nicastri E;Lepore L;Antinori A;Vergori A;Caccamo N;Cantini F;Girardi E;Ippolito G;Grifoni A;Goletti D
通讯作者:
Goletti D
影响因子:
64.5
作者:
Moderbacher, Carolyn Rydyznski;Ramirez, Sydney, I;Crotty, Shane
通讯作者:
Crotty, Shane
影响因子:
11.8
作者:
Schwarzkopf S;Krawczyk A;Knop D;Klump H;Heinold A;Heinemann FM;Thümmler L;Temme C;Breyer M;Witzke O;Dittmer U;Lenz V;Horn PA;Lindemann M
通讯作者:
Lindemann M
影响因子:
8.8
作者:
Meschi, Silvia;Colavita, Francesca;Castilletti, Concetta
通讯作者:
Castilletti, Concetta